Basic net loss per share is calculated by dividing net loss by the weighted-average number of Common Stock.

Diluted EPS is adjusted by the effect of dilutive securities, including options and awards under the Company’s equity compensation plans, warrants and ESPP. As a result of the Company’s net loss incurred for the three and nine months ended September 30, 2026 and 2025, all potentially dilutive instruments outstanding would have anti-dilutive effects on per-share calculations. Therefore, basic and diluted net loss per share are the same for the three and nine months ended September 30, 2026 and 2025 as reflected below.


	Three Months Ended September 30,				Nine Months Ended September 30,
	2026		2025		2026		2025
Numerator:
Net loss	$	(16,496)	$	(15,446)	$	(47,417)	$	(51,924)
Denominator:
Weighted-average number of common shares – basic and diluted	125,548,783		110,584,371		124,395,079		101,857,974






Loss per common share – basic and diluted	$	(0.13)	$	(0.14)	$	(0.38)	$	(0.51)

(a)For the three and nine months ended September 30, 2026 and 2025, outstanding stock options of 7,809,979 and 6,940,167 to purchase shares of Common Stock, respectively, were anti-dilutive.

(b)For the three and nine months ended September 30, 2026 and 2025, outstanding restricted stock units of 3,257,190 and 4,672,451 to purchase shares of Common Stock, respectively, were anti-dilutive.

(c)For the three and nine months ended September 30, 2026 and 2025, outstanding warrants of 2,805,271 and 2,360,548 to purchase shares of Common Stock, respectively, were anti-dilutive.